Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier to Work with Heel for Mechanism-based Drug Action Discovery

Posted on January 6th, 2021 by

Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies.

(more…)

Looking at Emerging Trends in Telemedicine

Posted on December 17th, 2020 by

Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers labored to deal with an influx of patients while also trying to mitigate coronavirus spread, telemedicine was urgently needed as an option for providing healthcare to others at a safe distance. In the U.S., the government and providers quickly started to take measures to facilitate its use during the crisis of the pandemic.

(more…)

3D Printing Makes Medical Devices More Personal

Posted on December 10th, 2020 by

Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly relevant in the area of medical devices.

(more…)

Pharma Industry Conferences Have Gone Online – Will They Stay There?

Posted on December 3rd, 2020 by

Back in 2014, writer Nick de Cent posed the question Is it time for the conference to go virtual? He interviewed digital healthcare consultant Len Starnes, who argued that bringing pharma and healthcare conferences online could be beneficial in many ways, most notably in expanding participation. Six years later, and COVID-19 forced the issue, prompting many conferences to go fully virtual.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 87